Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- C5119 fluoro-DapagliflozinSummary: selective sodium-glucose cotransporter (SGLT) inhibitor
- C5151 CetabenSummary: unique,PPARα-independent peroxisome proliferator
- C4828 Piriprost (potassium salt)Summary: 5-lipoxygenase inhibitor
- C5062 Fusaric AcidSummary: inhibitor of dopamine β-hydroxylase
- C5169 EA4Summary: rPLA2 inhibitor
- C5178 Methyl α-Linolenyl FluorophosphonateSummary: inhibitor of phospholipases, FAAH
- C5183 IbudilastSummary: inhibitor of PDE4
- C5221 galacto-DapagliflozinSummary: potent inhibitor of human SGLT2
- C5228 DDMSSummary: CYP4A2 enzyme inhibitor
- C5234 PPOHSummary: inhibitor of CYP epoxidase activity on arachadonic acid